Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
LONDON, April 17, 2026 — Yaqrit, a late clinical-stage company developing life-saving treatments for advanced liver diseases, today announce three international clinical papers outlining key, market-moving shifts in scientific evidence…